
    
      Inclusion Criteria & Outcome:

      Documented chronic hepatitis B infection positive serum HBV-DNA 10^5 copies/mL & above.

      Permanent efficacy response after whole treatment circle close(about 24 weeks,someone may be
      later than 24 weeks but within 48 weeks)

        -  HBeAg loss(if HBeAg positive)

        -  Liver Function normal(if Liver Function off normal)

        -  HBV DNA non-detectability (PCR <500 copies/ml)

        -  Image of chronic diffuse hepatic disease will recover up to normal if have.

        -  HBsAg titer will decrease continually up to loss after cessation of the treatment.

      Treatment Procedure:

      Patients will be involved in the study for up to 24-48 weeks from enrollment. There is no
      external sponsor, commercial sponsor nor governmental agency on this study. The study will be
      conducted only by Dr. Yu, Ke Heng,who is master of the Liquid Acupuncture(Herb Acupoint
      Injection)practice more than 30 years.About 30 subjects will be involved in the study
      overall. All the subjects can be filled up worldwide.

      Patients will be required to rent apartment or house for staying at the city(Xiamen
      city,China preferred).Dr. Yu will go to the Patients' site for treatment practice weekly,each
      4 weeks is one circle(the first 3 weeks for treatment practice and last week for Test
      collection).Appointed Hospitals for test must be certificated and qualified(Chang Gang
      Hospital preferred).Dr. Yu will explain the test results individually.
    
  